Skip to content

Kopin

US · KOPN #3394 by market cap
4.57 -0.31 -6.35%
Live - 5344 symbols - heartbeat 321s ago · 2026-10-08 09:19
Pre-market 4.54 -0.66%
After-hours 4.63 +1.31%
Overnight 4.61 +0.88%
Market cap
825.43M
P/B
11.93
EPS
0.01
Reader sentiment Are you bullish or bearish on KOPN?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Company notice
    SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
    SEC · 2024/11/14
  • Oppenheimer Initiates Kopin(KOPN.US) With Buy Rating, Announces Target Price $7
    Market Newswire · 2026/9/17
  • Rating change
    Analysts Offer Insights on Technology Companies: A10 Networks (ATEN), Gorilla Technology Group Inc. (GRRR) and Kopin (KOPN)
    TipRanks · 2026/9/15
  • Company notice
    Phio Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
    SEC · 2024/11/14
  • Rating change
    Lake Street Maintains Kopin(KOPN.US) With Buy Rating, Maintains Target Price $7
    Market Newswire · 2026/9/15
  • Fabric.AI Files Two U.S. Patent Applications For Micro-LED Optical Interconnect Tech Co-Developed With Kopin; Expects Hardware Demo In January 2027
    Benzinga · 2026/9/23
  • Rating change
    Craig-Hallum Maintains Kopin(KOPN.US) With Buy Rating, Maintains Target Price $10
    Market Newswire · 2026/8/11
  • Stifel Maintains Kopin(KOPN.US) With Buy Rating, Maintains Target Price $6.5
    Market Newswire · 2026/9/25
  • Rating change
    Stifel Maintains Kopin(KOPN.US) With Buy Rating, Raises Target Price to $6.5
    Market Newswire · 2026/5/13
  • Rating change
    Lucid Capital Initiates Kopin(KOPN.US) With Buy Rating, Announces Target Price $10
    Market Newswire · 2026/5/13
  • Rating change
    CCORF Initiates Kopin(KOPN.US) With Buy Rating, Announces Target Price $6.25
    Market Newswire · 2026/5/15
  • Company notice
    PainReform | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.5%),Daniel B. Asher(4.5%), etc.
    SEC · 2024/11/14
  • Company notice
    SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
    SEC · 2024/11/14
  • Rating change
    CCORF Maintains Kopin(KOPN.US) With Buy Rating, Raises Target Price to $5.5
    Market Newswire · 2026/5/9
  • Rating change
    Craig-Hallum Maintains Kopin(KOPN.US) With Buy Rating, Announces Target Price $10
    Market Newswire · 2026/5/13
  • Craig-Hallum Maintains Kopin(KOPN.US) With Buy Rating
    Market Newswire · 2026/9/18
  • Rating change
    A Quick Look at Today's Ratings for Kopin(KOPN.US), With a Forecast Between $6.25 to $10
    Market Newswire · 2026/5/14
  • Fabric.AI Files Two Patent Applications Covering Fiber-Coupled and Connector-Free MicroLED Optical Interconnect, Developed With Kopin
    GlobeNewswire · 2026/9/23
  • Company notice
    PharmaCyte Biotech | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Mitchell P. Kopin(9.99%),Daniel B. Asher(9.99%), etc.
    SEC · 2024/11/14
  • Rating change
    CCORF Maintains Kopin(KOPN.US) With Buy Rating, Raises Target Price to $6.5
    Market Newswire · 2026/8/20

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 09:19:20 · For reference only, not investment advice and not tailored to your situation.